INMED PHARMACEUTICALS Financials

You should never invest in INMED PHARMACEUTICALS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of INMED Stock, because this is throwing your money away. Analyzing the key information contained in INMED PHARMACEUTICALS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

INMED PHARMACEUTICALS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. INMED PHARMACEUTICALS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on INMED PHARMACEUTICALS INC correlated with the market. If Beta is less than 0 INMED PHARMACEUTICALS generally moves in the opposite direction as compared to the market. If INMED PHARMACEUTICALS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one INMED PHARMACEUTICALS INC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of INMED PHARMACEUTICALS is generally in the same direction as the market. If Beta > 1 INMED PHARMACEUTICALS moves generally in the same direction as, but more than the movement of the benchmark.